HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Humanigen, Inc. (NASDAQ: HGEN)....

Related Keywords

New York ,United States , ,Humanigen Inc ,Drug Administration ,Nasdaq ,Emergency Use Authorization ,Jakubowitz Law ,